Source: Eur Respir J 2010; 36: 1346-1354
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Schouten M., van der Sluijs K.F., Roelofs J.J.T.H., Levi M., van't Veer C., van der Poll T.. Factor V Leiden mutation does not affect coagulopathy or outcome in lethal H1N1 influenza. Eur Respir J 2010; 36: 1346-1354

Member's Comments

No comment yet.

Related content which might interest you: Risk of venous thromboembolism (VTE) in first degree relatives (FDRS) of patients with unprovoked VTE who do not have factor V Leiden (FVL) or the G20210A prothrombin gene mutation (PGM) Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Impact of recombinant factor VIIa (rFVIIa) on transfusion related acute lung injury (TRALI) Source: Eur Respir J 2006; 28: Suppl. 50, 180s Year: 2006 The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 56 (4) 2000774; 10.1183/13993003.00774-2020 Year: 2020 The role of thrombophilic risk factors in the severity of pulmonary thromboembolism Source: Eur Respir J 2002; 19: 709-711 Year: 2002 PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 Genetic variants associated with severe pneumonia in A/H1N1 influenza infection Source: Eur Respir J 2012; 39: 604-610 Year: 2012 The impact of screening for factor V Leiden (FVL) first degree relatives of patients with venous thromboembolism (VTE) and FVL on their risk of VTE Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Obesity as the most considerable risk factor for death due to influenza A/H1N1-09 viral infection Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Factors that predict the risk of recurrent venous thromboembolism (VTE) in patients with VTE and factor V Leiden (FVL) Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Influenza type A outbreak associated with myositis Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005 Tumour necrosis factor and signal transducer and activator of transcription 3 pathways; novel targets to treat severe influenza virus infection Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 The G20210A polymorphism of the prothrombin gene is the strong genetic risk factor for the pulmonary embolism development in young patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 H1N1pdm09 is an independent risk factor for severe influenza Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Higher plasma total homocysteine (tHcy) level and abnormal methionine loading test (MLT) in family members of patients with pulmonary embolism (PE) and carriers of factor V Leiden (FVL) Source: Annual Congress 2004 - Pulmonary embolism Year: 2004 Avian influenza and SARS – how much of a threat is it to humans and what can be done to prevent this? Source: Annual Congress 2005 - Major viral threats to the lung Year: 2005 Infection of human peribronchial gland cells (PBGC) with respiratory syncytial virus (RSV) shows a interaction of RSV with the nuclear factor (NF) κB-complex Source: Eur Respir J 2001; 18: Suppl. 33, 305s Year: 2001 Respiratory viral agents in cystic fibrosis Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome Source: Eur Respir J 2001; 17: 636-640 Year: 2001 Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis Source: Eur Respir J 2003; 21: 25-30 Year: 2003 Prothrombin gene variant (20210A) as cause of thromboembolic events in a young pregnant woman Source: Eur Respir J 2001; 18: Suppl. 33, 382s Year: 2001